Behavioral Interventions in Tobacco Dependence

Primary Care - Clinics in Office Practice

Volumn 36, Issue 3, 2009, Pages 489-507

  Leone, Frank T ^a,b   Evers Casey, Sarah ^b  

^a Cardiovascular Pulmonary Division   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Behavioral Medicine; Cessation; Counseling; Dependence; Smoking; Tobacco

Indexed keywords

AMFEBUTAMONE; CLONIDINE; NICOTINE; NICOTINE GUM; NICOTINE PATCH; NORTRIPTYLINE; NOSE SPRAY; PAROXETINE; PLACEBO; VARENICLINE; VENLAFAXINE;

AGITATION; BEHAVIOR DISORDER; BEHAVIOR MODIFICATION; CIGARETTE SMOKING; CLINICAL TRIAL; COMPULSION; CORONARY ARTERY DISEASE; DEPRESSION; DRUG DELIVERY SYSTEM; DRUG DOSE TITRATION; DRUG OVERDOSE; DYSPEPSIA; HEALTH CARE DELIVERY; HEALTH HAZARD; HEART INFARCTION; HEART PALPITATION; HUMAN; LIFESTYLE MODIFICATION; NAUSEA; NICOTINE REPLACEMENT THERAPY; PATIENT CARE PLANNING; PATIENT COUNSELING; PRACTICE GUIDELINE; PRIORITY JOURNAL; PSYCHOLOGICAL WELL BEING; REVIEW; RISK REDUCTION; SIDE EFFECT; SKIN IRRITATION; SLEEP DISORDER; SMOKING CESSATION PROGRAM; SMOKING HABIT; SUICIDAL IDEATION; SUICIDE ATTEMPT; TACHYCARDIA; TOBACCO DEPENDENCE;

ANTIDEPRESSIVE AGENTS; BEHAVIOR THERAPY; HEALTH BEHAVIOR; HUMANS; MOTIVATION; NICOTINIC AGONISTS; PRIMARY HEALTH CARE; SMOKING CESSATION; TOBACCO USE DISORDER;

EID: 67651108997     PISSN: 00954543     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pop.2009.04.002     Document Type: Review

References (66)

1. Centers for Disease Control and Prevention. Cigarette smoking among adults - United States, 2006. MMWR Morb Mortal Wkly Rep 56 (2007) 1157-1161
2. McMillen R.C., Winickoff J.P., Klein J.D., et al. US adult attitudes and practices regarding smoking restrictions and child exposure to environmental tobacco smoke: changes in the social climate from 2000-2001. Pediatrics 112 (2003) e55-e60
3. Centers for Disease Control. Public attitudes regarding limits on public smoking and regulation of tobacco sales and advertising-10 U.S. communities, 1989. MMWR Morb Mortal Wkly Rep 40 (1991) 344-345
4. Centers for Disease Control and Prevention. State-specific prevalence of cigarette smoking among adults and quitting among persons aged 18-35 years - United States, 2006. MMWR Morb Mortal Wkly Rep 56 (2007) 993-996
5. Batra V, Leone F, Patkar A, et al. Health beliefs of Pennsylvania physicians regarding smoking cessation counseling. Proceedings of the Society for Research in Nicotine and Tobacco. March 2001[PO1 34], 42. 2001.
6. Evers-Casey S, Patkar A, Weibel S, et al. Tobacco-related knowledge and attitudes do not relate to provider self-efficacy. Proceedings of the Society for Research on Nicotine and Tobacco. [RP-030], S08. 2004.
7. Garg A., Serwint J.R., Higman S., et al. Self-efficacy for smoking cessation counseling parents in primary care: an office-based intervention for pediatricians and family physicians. Clin Pediatr (Phila) 46 (2007) 252-257
8. Cabana M.D., Rand C., Slish K., et al. Pediatrician self-efficacy for counseling parents of asthmatic children to quit smoking. Pediatrics 113 (2004) 78-81
9. Chaudhri N., Caggiula A.R., Donny E.C., et al. Complex interactions between nicotine and nonpharmacological stimuli reveal multiple roles for nicotine in reinforcement. Psychopharmacology (Berl) 184 (2006) 353-366
10. Rose J.E., and Levin E.D. Inter-relationships between conditioned and primary reinforcement in the maintenance of cigarette smoking. Br J Addict 86 (1991) 605-609
11. Perkins K.A. Nicotine self-administration. Nicotine Tob Res 2 Suppl 1 (1999) S133-S137
12. Balfour D.J., Wright A.E., Benwell M.E., et al. The putative role of extra-synaptic mesolimbic dopamine in the neurobiology of nicotine dependence. Behav Brain Res 113 (2000) 73-83
13. Caggiula A.R., Donny E.C., White A.R., et al. Cue dependency of nicotine self-administration and smoking. Pharmacol Biochem Behav 70 (2001) 515-530
14. Testing drugs for physical dependence potential and abuse liability. The Committee on Problems of Drug Dependence, Inc. NIDA Res Monogr 52 (1984) 1-153
15. Hebb D.O. The organization of behavior, a neuropsychological theory (1949), Wiley, New York
16. Hyman S.E., Malenka R.C., and Nestler E.J. Neural mechanisms of addiction: the role of reward-related learning and memory. Annu Rev Neurosci 29 (2006) 565-598
17. Hyman S.E. Addiction: a disease of learning and memory. Am J Psychiatry 162 (2005) 1414-1422
18. Grove R.N., and Schuster C.R. Suppression of cocaine self-administration by extinction and punishment. Pharmacol Biochem Behav 2 (1974) 199-208
19. Smith S.G., and Davis W.M. Punishment of amphetamine and morphine self-administration behavior. Psychol Rec 24 (1974) 477-480
20. Stolerman I. Animal models for nicotine dependence. In: Novartis Foundation (Ed). Understanding nicotine and tobacco addiction (2006), John Wiley and Sons, Chichester (UK) 17-35
21. LeFoll B., Wertheim C., and Goldberg S.R. High reinforcing efficacy of nicotine in non-human primates. PLoS ONE 2 (2007) e230
22. Balfour D.J. The neurobiology of tobacco dependence: a preclinical perspective on the role of the dopamine projections to the nucleus accumbens. [corrected]. Nicotine Tob Res 6 (2004) 899-912
23. Janis I., and Mann L. Decision making: a psychological analysis of conflict, choice, and commitment (1977), Free Press, New York
24. Miller W.R., and Rollnick S. Motivational interviewing: preparing people to change (2002), Guilford Press, New York
25. Sweet A. The therapeutic relationship in behavior therapy. Clin Psychol Rev 4 (1984) 253-272
26. Fiore M.C., Jaén C.R., Baker T.B., et al. Treating tobacco use and dependence: 2008 update. Clinical practice guideline (2008), US Department of Health and Human Services, Public Health Service, Rockville (MD)
27. Fiore M.C., Novotny T.E., Pierce J.P., et al. Methods used to quit smoking in the United States. Do cessation programs help?. JAMA 263 (1990) 2760-2765
28. Samet J.M. The 1990 report of the surgeon general: the health benefits of smoking cessation. Am Rev Respir Dis 142 (1990) 993-994
29. Silagy C., Lancaster T., Stead L., et al. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev 3 (2001) CD000146
30. Silagy C., Mant D., Fowler G., et al. Meta-analysis on efficacy of nicotine replacement therapies in smoking cessation. Lancet 343 (1994) 139-142
31. Hughes J.R., and Hatsukami D. Signs and symptoms of tobacco withdrawal. Arch Gen Psychiatry 43 (1986) 289-294
32. Henningfield J.E., and Keenan R.M. Nicotine delivery kinetics and abuse liability. J Consult Clin Psychol 61 (1993) 743-750
33. Rigotti N.A. Clinical practice. Treatment of tobacco use and dependence. N Engl J Med 346 (2002) 506-512
34. Shiffman S., Hughes J.R., Pillitteri J.L., et al. Persistent use of nicotine replacement therapy: an analysis of actual purchase patterns in a population based sample. Tob Control 12 (2003) 310-316
35. Fiore M.C. US Public Health Service clinical practice guideline: treating tobacco use and dependence. Respir Care 45 (2000) 1200-1262
36. Hughes J.R., Lesmes G.R., Hatsukami D.K., et al. Are higher doses of nicotine replacement more effective for smoking cessation?. Nicotine Tob Res 1 (1999) 169-174
37. Foulds J., Stapleton J., Feyerabend C., et al. Effect of transdermal nicotine patches on cigarette smoking: a double blind crossover study. Psychopharmacology (Berl) 106 (1992) 421-427
38. Carpenter M.J., Hughes J.R., and Keely J.P. Effect of smoking reduction on later cessation: a pilot experimental study. Nicotine Tob Res 5 (2003) 155-162
39. Hurt R.D., Dale L.C., Offord K.P., et al. Serum nicotine and cotinine levels during nicotine-patch therapy. Clin Pharmacol Ther 54 (1993) 98-106
40. Hurt R.D., Dale L.C., Fredrickson P.A., et al. Nicotine patch therapy for smoking cessation combined with physician advice and nurse follow-up. One-year outcome and percentage of nicotine replacement. JAMA 271 (1994) 595-600
41. Henningfield J.E., Stapleton J.M., Benowitz N.L., et al. Higher levels of nicotine in arterial than in venous blood after cigarette smoking. Drug Alcohol Depend 33 (1993) 23-29
42. Porchet H.C., Benowitz N.L., Sheiner L.B., et al. Apparent tolerance to the acute effect of nicotine results in part from distribution kinetics. J Clin Invest 80 (1987) 1466-1471
43. Kimmel S.E., Berlin J.A., Miles C., et al. Risk of acute first myocardial infarction and use of nicotine patches in a general population. J Am Coll Cardiol 37 (2001) 1297-1302
44. Nicotine replacement therapy for patients with coronary artery disease. Working Group for the Study of Transdermal Nicotine in Patients with Coronary artery disease. Arch Intern Med 154 (1994) 989-995
45. Meine T.J., Patel M.R., Washam J.B., et al. Safety and effectiveness of transdermal nicotine patch in smokers admitted with acute coronary syndromes. Am J Cardiol 95 (2005) 976-978
46. Fiore M.C., Smith S.S., Jorenby D.E., et al. The effectiveness of the nicotine patch for smoking cessation. A meta-analysis. JAMA 271 (1994) 1940-1947
47. A clinical practice guideline for treating tobacco use and dependence: A US Public Health Service report. The tobacco use and dependence clinical practice guideline panel, staff, and consortium representatives. JAMA 283 (2000) 3244-3254
48. Kornitzer M., Boutsen M., Dramaix M., et al. Combined use of nicotine patch and gum in smoking cessation: a placebo-controlled clinical trial. Prev Med 24 (1995) 41-47
49. Bohadana A., Nilsson F., Rasmussen T., et al. Nicotine inhaler and nicotine patch as a combination therapy for smoking cessation: a randomized, double-blind, placebo-controlled trial. Arch Intern Med 160 (2000) 3128-3134
50. Blondal T., Gudmundsson L.J., Olafsdottir I., et al. Nicotine nasal spray with nicotine patch for smoking cessation: randomized trial with six year follow up. BMJ 318 (1999) 285-288
51. Benowitz N.L. Nicotine replacement therapy. What has been accomplished - can we do better?. Drugs 45 (1993) 157-170
52. Shiffman S., Dresler C.M., Hajek P., et al. Efficacy of a nicotine lozenge for smoking cessation. Arch Intern Med 162 (2002) 1267-1276
53. Blondal T., Franzon M., and Westin A. A double-blind randomized trial of nicotine nasal spray as an aid in smoking cessation. Eur Respir J 10 (1997) 1585-1590
54. Lerman C., Kaufmann V., Rukstalis M., et al. Individualizing nicotine replacement therapy for the treatment of tobacco dependence: a randomized trial. Ann Intern Med 140 (2004) 426-433
55. Stahl S.M., Pradko J.F., Haight B.R., et al. A review of the neuropharmacology of bupropion, a dual norepinephrine and dopamine reuptake inhibitor. Prim Care Companion J Clin Psychiatry 6 (2004) 159-166
56. Holm K.J., and Spencer C.M. Bupropion: a review of its use in the management of smoking cessation. Drugs 59 (2000) 1007-1024
57. Jorenby D.E., Leischow S.J., Nides M.A., et al. A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation. N Engl J Med 340 (1999) 685-691
58. Jamerson B.D., Nides M., Jorenby D.E., et al. Late-term smoking cessation despite initial failure: an evaluation of bupropion sustained release, nicotine patch, combination therapy, and placebo. Clin Ther 23 (2001) 744-752
59. Jorenby D. Clinical efficacy of bupropion in the management of smoking cessation. Drugs 62 Suppl 2 (2002) 25-35
60. Rollema H., Chambers L.K., Coe J.W., et al. Pharmacological profile of the alpha4beta2 nicotinic acetylcholine receptor partial agonist varenicline, an effective smoking cessation aid. Neuropharmacology 52 (2007) 985-994
61. Gonzales D., Rennard S.I., Nides M., et al. Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs. sustained-release bupropion and placebo for smoking cessation: a randomized controlled trial. JAMA 296 (2006) 47-55
62. Jorenby D.E., Hays J.T., Rigotti N.A., et al. Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs. placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial. JAMA 296 (2006) 56-63
63. Tonstad S., Tonnesen P., Hajek P., et al. Effect of maintenance therapy with varenicline on smoking cessation: a randomized controlled trial. JAMA 296 (2006) 64-71
64. Niaura R., Hays J.T., Jorenby D.E., et al. The efficacy and safety of varenicline for smoking cessation using a flexible dosing strategy in adult smokers: a randomized controlled trial. Curr Med Res Opin 24 (2008) 1931-1941
65. Williams K.E., Reeves K.R., Billing C.B., et al. A double-blind study evaluating the long-term safety of varenicline for smoking cessation. Curr Med Res Opin 23 (2007) 793-801
66. US Food and Drug Administration. Medication guide: Chantix. Available at. http://www.fda.gov/downloads/Drugs/DrugSafety/ucm088569.pdf Accessed June 22, 2009